Total Funding
66
59
Total FundingGrant raised
Growth Score 66 in past quarter
-4 pts
Heat Score 59 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
135488
StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors.
- Anthony McHale: CSO
- Sian Farrell: CEO & Co-Founder
About the Company
StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F